Zobrazeno 1 - 10
of 2 290
pro vyhledávání: '"A F, Baas"'
Autor:
S. Voigt, E. A. Koemans, I. Rasing, E. S. van Etten, G. M. Terwindt, F. Baas, K. Kaushik, A. C. G. M. van Es, M. A. van Buchem, M. J. P. van Osch, M. A. A. van Walderveen, C. J. M. Klijn, M. M. Verbeek, L. van der Weerd, M. J. H. Wermer
Publikováno v:
Trials, Vol 24, Iss 1, Pp 1-6 (2023)
Abstract Background Cerebral amyloid angiopathy (CAA) is a disease caused by the accumulation of the amyloid-beta protein and is a major cause of intracerebral hemorrhage (ICH) and vascular dementia in the elderly. The presence of the amyloid-beta pr
Externí odkaz:
https://doaj.org/article/aea914d44b86478b88e22d6bbf1175f2
Autor:
Mark Jansen, Sila Algül, Laurens P. Bosman, Michelle Michels, Jolanda van derVelden, Rudolf A. deBoer, J. Peter vanTintelen, Folkert W. Asselbergs, Annette F. Baas
Publikováno v:
ESC Heart Failure, Vol 9, Iss 5, Pp 3418-3434 (2022)
Abstract Aims Hypertrophic cardiomyopathy (HCM) is the most prevalent monogenic heart disease. HCM is an important cause of sudden cardiac death and may also lead to outflow tract obstruction and heart failure. Disease severity is highly variable and
Externí odkaz:
https://doaj.org/article/3d00034d775d4521800ec77de51f9351
Autor:
Arjan Sammani, Ayoub Bagheri, Peter G. M. van der Heijden, Anneline S. J. M. te Riele, Annette F. Baas, C. A. J. Oosters, Daniel Oberski, Folkert W. Asselbergs
Publikováno v:
npj Digital Medicine, Vol 4, Iss 1, Pp 1-10 (2021)
Abstract Standard reference terminology of diagnoses and risk factors is crucial for billing, epidemiological studies, and inter/intranational comparisons of diseases. The International Classification of Disease (ICD) is a standardized and widely use
Externí odkaz:
https://doaj.org/article/0f7e2a6ca61e4c53a1d2909562865f85
Autor:
Arjan Sammani, Mark Jansen, Nynke M. de Vries, Nicolaas de Jonge, Annette F. Baas, Anneline S. J. M. te Riele, Folkert W. Asselbergs, Marish I. F. J. Oerlemans
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
BackgroundUnexplained Left Ventricular Hypertrophy (ULVH) may be caused by genetic and non-genetic etiologies (e.g., sarcomere variants, cardiac amyloid, or Anderson-Fabry's disease). Identification of ULVH patients allows for early targeted treatmen
Externí odkaz:
https://doaj.org/article/ce7c52024cfe434aa38d91bf60edf0e2
Autor:
Steven A. Muller, Alessio Gasperetti, Laurens P. Bosman, Amand F. Schmidt, Annette F. Baas, Ahmad S. Amin, Arjan C. Houweling, Arthur A.M. Wilde, Paolo Compagnucci, Mattia Targetti, Michela Casella, Leonardo Calò, Claudio Tondo, Pim van der Harst, Folkert W. Asselbergs, J. Peter van Tintelen, Marish I.F.J. Oerlemans, Anneline S.J.M. Te Riele
Publikováno v:
Muller, S A, Gasperetti, A, Bosman, L P, Schmidt, A F, Baas, A F, Amin, A S, Houweling, A C, Wilde, A A M, Compagnucci, P, Targetti, M, Casella, M, Calò, L, Tondo, C, van der Harst, P, Asselbergs, F W, van Tintelen, J P, Oerlemans, M I F J & te Riele, A S J M 2023, ' Individualized Family Screening for Arrhythmogenic Right Ventricular Cardiomyopathy ', Journal of the American College of Cardiology, vol. 82, no. 3, pp. 214-225 . https://doi.org/10.1016/j.jacc.2023.05.005
Background: Clinical guidelines recommend regular screening for arrhythmogenic right ventricular cardiomyopathy (ARVC) to monitor at-risk relatives, resulting in a significant burden on clinical resources. Prioritizing relatives on their probability
Autor:
Maike Schuldt, Beau van Driel, Sila Algül, Rahana Y. Parbhudayal, Daniela Q. C. M. Barge-Schaapveld, Ahmet Güçlü, Mark Jansen, Michelle Michels, Annette F. Baas, Mark A. van de Wiel, Max Nieuwdorp, Evgeni Levin, Tjeerd Germans, Judith J. M. Jans, Jolanda van der Velden
Publikováno v:
Cells, Vol 10, Iss 11, p 2950 (2021)
Hypertrophic Cardiomyopathy (HCM) is a common inherited heart disease with poor risk prediction due to incomplete penetrance and a lack of clear genotype–phenotype correlations. Advanced imaging techniques have shown altered myocardial energetics a
Externí odkaz:
https://doaj.org/article/a9ba77202bd64ddd8d0b7f6a3dbc9ef4
Autor:
J Peter van Tintelen, Imke Christiaans, Lieke M van den Heuvel, Yvonne M Hoedemaekers, Annette F Baas, Ellen M A Smets
Publikováno v:
BMJ Open, Vol 9, Iss 7 (2019)
Introduction In current practice, probands are asked to inform relatives about the possibility of predictive DNA testing when a pathogenic variant causing an inherited cardiac condition (ICC) is identified. Previous research on the uptake of genetic
Externí odkaz:
https://doaj.org/article/28b47ad61ecf4d37ae76a46690eba056
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Mark Jansen, Maike Schuldt, Beau O. van Driel, Amand F. Schmidt, Imke Christiaans, Saskia N. van der Crabben, Yvonne M. Hoedemaekers, Dennis Dooijes, Jan D. H. Jongbloed, Ludolf G. Boven, Ronald H. Lekanne Deprez, Arthur A. M. Wilde, Judith J. M. Jans, Jolanda van der Velden, Rudolf A. de Boer, J. Peter van Tintelen, Folkert W. Asselbergs, Annette F. Baas
Publikováno v:
International journal of molecular sciences, 24(4):4031. Multidisciplinary Digital Publishing Institute (MDPI)
International Journal of Molecular Sciences, 24(4):4031. MDPI AG
International Journal of Molecular Sciences, 24(4):4031. Multidisciplinary Digital Publishing Institute (MDPI)
International Journal of Molecular Sciences
Volume 24
Issue 4
Pages: 4031
International Journal of Molecular Sciences, 24, 4
International Journal of Molecular Sciences, 24
Jansen, M, Schuldt, M, van Driel, B O, Schmidt, A F, Christiaans, I, van der Crabben, S N, Hoedemaekers, Y M, Dooijes, D, Jongbloed, J D H, Boven, L G, Deprez, R H L, Wilde, A A M, Jans, J J M, van der Velden, J, de Boer, R A, van Tintelen, J P, Asselbergs, F W & Baas, A F 2023, ' Untargeted Metabolomics Identifies Potential Hypertrophic Cardiomyopathy Biomarkers in Carriers of MYBPC3 Founder Variants ', International Journal of Molecular Sciences, vol. 24, no. 4, 4031 . https://doi.org/10.3390/ijms24044031
International Journal of Molecular Sciences, 24(4):4031. MDPI AG
International Journal of Molecular Sciences, 24(4):4031. Multidisciplinary Digital Publishing Institute (MDPI)
International Journal of Molecular Sciences
Volume 24
Issue 4
Pages: 4031
International Journal of Molecular Sciences, 24, 4
International Journal of Molecular Sciences, 24
Jansen, M, Schuldt, M, van Driel, B O, Schmidt, A F, Christiaans, I, van der Crabben, S N, Hoedemaekers, Y M, Dooijes, D, Jongbloed, J D H, Boven, L G, Deprez, R H L, Wilde, A A M, Jans, J J M, van der Velden, J, de Boer, R A, van Tintelen, J P, Asselbergs, F W & Baas, A F 2023, ' Untargeted Metabolomics Identifies Potential Hypertrophic Cardiomyopathy Biomarkers in Carriers of MYBPC3 Founder Variants ', International Journal of Molecular Sciences, vol. 24, no. 4, 4031 . https://doi.org/10.3390/ijms24044031
Hypertrophic cardiomyopathy (HCM) is the most prevalent monogenic heart disease, commonly caused by pathogenic MYBPC3 variants, and a significant cause of sudden cardiac death. Severity is highly variable, with incomplete penetrance among genotype-po
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d72bb1c895193fff307bea1dc49f526e
https://pure.amc.nl/en/publications/untargeted-metabolomics-identifies-potential-hypertrophic-cardiomyopathy-biomarkers-in-carriers-of-mybpc3-founder-variants(d14b78ac-9af3-4c14-8c03-92cca76f9660).html
https://pure.amc.nl/en/publications/untargeted-metabolomics-identifies-potential-hypertrophic-cardiomyopathy-biomarkers-in-carriers-of-mybpc3-founder-variants(d14b78ac-9af3-4c14-8c03-92cca76f9660).html
Autor:
Mimount Bourfiss, Marion van Vugt, Abdulrahman I. Alasiri, Bram Ruijsink, Jessica van Setten, A. Floriaan Schmidt, Dennis Dooijes, Esther Puyol-Antón, Birgitta K. Velthuis, J. Peter van Tintelen, Anneline S.J.M. te Riele, Annette F. Baas, Folkert W. Asselbergs
Publikováno v:
Circulation: Genomic and Precision Medicine. 15
Background: Pathogenic and likely pathogenic variants associated with arrhythmogenic right ventricular cardiomyopathy (ARVC), dilated cardiomyopathy (DCM), and hypertrophic cardiomyopathy (HCM) are recommended to be reported as secondary findings in